Up group, n = 27 | Down group, n = 16 | ||
---|---|---|---|
Gender (M) | 20 (74%) | 10 (63%) | p = 0.638 |
Gestational age | 27.26 ± 3.59 | 27.25 ± 4.60 | p = 0.637 |
Birth weight, g | 992 ± 613 | 984 ± 663 | p = 0.315 |
Ethnicity (n) | |||
Caucasian | 10 | 5 | p = 0.185 |
African American | 11 | 3 | |
Hispanic | 3 | 6 | |
Asian | 1 | 0 | |
Unknown | 2 | 2 | |
Length of stay, days | 129.52 ± 67.67 | 141.31 ± 58.11 | p = 0.499 |
Duration of PN, days | 53.96 | 49.63 | p = 0.421 |
Intrauterine growth retardation (IUGR) | 2 | 1 | p = 1.00 |
Age at EN initiation, days | 11.15 ± 13.80 | 24.13 ± 22.53 | p = 0.037 |
Type of EN (n) | p = 0.573 | ||
BM | 8 | 3 | |
Standard formula | 13 | 11 | |
Protein hydrosylate | 2 | 0 | |
Amino Acid | 4 | 2 | |
Route of feeding administration (n) | p = 0.196 | ||
PO/bolus | 25 | 13 | |
Continuous | 1 | 0 | |
Combination | 1 | 3 | |
Ursodiol use (n) | 19 | 8 | p = 0.182 |
Start & stop before PN cessation | |||
Start before, stop after PN cessation | 9 | 2 | |
Start and stop after PN cessation | 13 | 4 | |
Sepsis (n) | 14 | 8 | p = 0.578 |
Occurred before PN cessation | 13 | 5 | p = 0.117 |
Occurred after PN cessation | 1 | 2 | |
Occurred before and after PN cessation | 0 | 1 | |
Gram negative sepsis | 5 | 3 | p = 0.642 |
Occurred before PN cessation | 5 | 2 | p = 0.375 |
Occurred after PN cessation | 0 | 1 | |
Rate of normalization (CB < 2 mg/dL) | 16 | 12 | p = 0.295 |